CN101804090B - 用于治疗前列腺疾病的片剂制备方法及其用途 - Google Patents
用于治疗前列腺疾病的片剂制备方法及其用途 Download PDFInfo
- Publication number
- CN101804090B CN101804090B CN2010101666859A CN201010166685A CN101804090B CN 101804090 B CN101804090 B CN 101804090B CN 2010101666859 A CN2010101666859 A CN 2010101666859A CN 201010166685 A CN201010166685 A CN 201010166685A CN 101804090 B CN101804090 B CN 101804090B
- Authority
- CN
- China
- Prior art keywords
- tablet
- gryllotalpa
- chinese medicine
- concocted
- corium erinacei
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 208000017497 prostate disease Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims abstract description 65
- 239000003814 drug Substances 0.000 claims abstract description 43
- 239000011248 coating agent Substances 0.000 claims abstract description 36
- 238000000576 coating method Methods 0.000 claims abstract description 36
- 239000000843 powder Substances 0.000 claims abstract description 29
- 239000000463 material Substances 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims abstract description 7
- 238000010992 reflux Methods 0.000 claims abstract description 6
- 238000003809 water extraction Methods 0.000 claims abstract description 6
- 241001243091 Gryllotalpa Species 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 26
- -1 hydroxypropyl Chemical group 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 16
- 239000001856 Ethyl cellulose Substances 0.000 claims description 12
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 12
- 229920001249 ethyl cellulose Polymers 0.000 claims description 12
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 12
- 239000007931 coated granule Substances 0.000 claims description 10
- 239000012567 medical material Substances 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 239000004576 sand Substances 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 5
- 235000015099 wheat brans Nutrition 0.000 claims description 4
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims description 3
- 241000533849 Gleditsia Species 0.000 claims description 3
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- 201000007094 prostatitis Diseases 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 230000002485 urinary effect Effects 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 238000000605 extraction Methods 0.000 abstract description 4
- 238000010298 pulverizing process Methods 0.000 abstract description 4
- 239000002245 particle Substances 0.000 abstract description 3
- 244000005852 Adiantum capillus veneris Species 0.000 abstract 2
- 235000013211 Adiantum capillus veneris Nutrition 0.000 abstract 2
- 241000289669 Erinaceus europaeus Species 0.000 abstract 2
- 241000241125 Gryllotalpa gryllotalpa Species 0.000 abstract 2
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 16
- 238000005516 engineering process Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- SQFSKOYWJBQGKQ-UHFFFAOYSA-N kaempferide Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 SQFSKOYWJBQGKQ-UHFFFAOYSA-N 0.000 description 4
- 235000014593 oils and fats Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 201000009442 piebaldism Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Abstract
Description
样品 | I组(分钟) | II组(分钟) | III组(分钟) | 平均(分钟) |
本发明制成的片剂 | 26 | 29 | 27 | 27 |
常规技术制成的片剂 | 49 | 52 | 51 | 50 |
样品 | I组 | II组 | III组 | 平均 |
本发明制成的片剂 | 损失重量0.67%未见碎片、裂片 | 损失重量0.62%未见碎片、裂片 | 损失重量0.59%未见碎片、裂片 | 损失重量0.63%未见碎片 |
常规技术制成的片剂 | 损失重量1.1%一片裂片 | 损失重量1.2%二片裂片 | 损失重量1.1%一片裂片 | 损失重量1.1%一片裂片 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101666859A CN101804090B (zh) | 2010-04-27 | 2010-04-27 | 用于治疗前列腺疾病的片剂制备方法及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101666859A CN101804090B (zh) | 2010-04-27 | 2010-04-27 | 用于治疗前列腺疾病的片剂制备方法及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101804090A CN101804090A (zh) | 2010-08-18 |
CN101804090B true CN101804090B (zh) | 2013-02-13 |
Family
ID=42606150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101666859A Active CN101804090B (zh) | 2010-04-27 | 2010-04-27 | 用于治疗前列腺疾病的片剂制备方法及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101804090B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102258557B (zh) * | 2011-06-03 | 2013-08-28 | 淮阴工学院 | 一种用于治疗前列腺增生的药物 |
CN104130231B (zh) * | 2014-07-04 | 2016-01-27 | 芜湖欧标农业发展有限公司 | 一种从翅柄铁线蕨中提取槲皮素的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1476877A (zh) * | 2003-04-01 | 2004-02-25 | 贵州太和制药有限公司 | 治疗前列腺疾病的药物及其制备方法 |
CN1973849A (zh) * | 2006-12-25 | 2007-06-06 | 河南辅仁药业集团有限公司 | 一种用于利尿通淋的药物组合物及其制备方法 |
CN101618063A (zh) * | 2009-03-30 | 2010-01-06 | 贵州太和制药有限公司 | 一种治疗前列腺疾病的药物及其制备方法 |
-
2010
- 2010-04-27 CN CN2010101666859A patent/CN101804090B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1476877A (zh) * | 2003-04-01 | 2004-02-25 | 贵州太和制药有限公司 | 治疗前列腺疾病的药物及其制备方法 |
CN1973849A (zh) * | 2006-12-25 | 2007-06-06 | 河南辅仁药业集团有限公司 | 一种用于利尿通淋的药物组合物及其制备方法 |
CN101618063A (zh) * | 2009-03-30 | 2010-01-06 | 贵州太和制药有限公司 | 一种治疗前列腺疾病的药物及其制备方法 |
Non-Patent Citations (4)
Title |
---|
王琰等.王不留行炮制技术探讨.《山东中医杂志》.2006,第25卷(第1期),57-59. * |
罗明生等.药用辅料在固体制剂中的应用技术.《中国药用辅料》.化学工业出版社,2006,(第1版),217. * |
赵振宇.颗粒剂包衣材料的现状.《天津药学》.2003,第15卷(第4期),59-62. * |
高文平等.薄膜包衣在参芪胶囊中的应用.《陕西中医》.2006,第27卷(第10期),1289. * |
Also Published As
Publication number | Publication date |
---|---|
CN101804090A (zh) | 2010-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104383123A (zh) | 一种金花茶降脂降糖制剂的制备方法 | |
CN104856968B (zh) | 一种具有消栓通络作用的中药片剂及其制备方法 | |
CN102772444A (zh) | 中药超微破壁口服片剂饮片的加工方法 | |
CN115120683A (zh) | 原料组合物和中药发酵产品及其制备方法和应用 | |
CN102772440A (zh) | 中药超微破壁口服片剂饮片的加工方法 | |
CN101057925B (zh) | 接骨七厘胶囊制备工艺 | |
CN108770989A (zh) | 一种具有预防骨质疏松作用的牛骨胶原蛋白肽的制备方法 | |
CN102319357B (zh) | 一种降脂灵分散片及其制备工艺 | |
CN101804090B (zh) | 用于治疗前列腺疾病的片剂制备方法及其用途 | |
CN100367940C (zh) | 妇宁康薄膜衣片的制备方法 | |
CN105664018A (zh) | 一种利胆排石片及其制备方法 | |
CN113209166A (zh) | 一种含烟酰胺单核苷酸的抗衰老中药组合物及其制备方法 | |
CN109528901B (zh) | 红金消结片的制备工艺 | |
CN104474195A (zh) | 一种治疗白癜风的中药复方制剂及其制备方法 | |
CN100556426C (zh) | 治疗骨科疾病的抗骨增生制剂及其制法和检测方法 | |
CN1853670B (zh) | 冠心丹参微丸制剂及其制备方法 | |
CN109922816A (zh) | 包含花粉和/或雌蕊提取物的组合物、其制备工艺和相关用途 | |
CN101708307A (zh) | 一种用于治疗乳腺增生的药物及其制法 | |
CN105641672A (zh) | 治疗能量代谢失衡引起的肥胖症的组合物及制剂 | |
CN102772439A (zh) | 中药超微破壁胶囊剂饮片的加工方法 | |
CN100509048C (zh) | 金乌骨通片及其制备方法 | |
CN112544973B (zh) | 一种辅助降血脂组合物,由其制备的复方颗粒以及制备方法和用途 | |
CN100512871C (zh) | 治疗胆囊炎的薄膜衣片的制备方法 | |
CN103565752B (zh) | 一种祛风生发的斑秃微丸 | |
CN1931337A (zh) | 金刚藤微丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tablet used for treating prostate diseases as well as preparation method and application thereof Effective date of registration: 20130717 Granted publication date: 20130213 Pledgee: Agricultural Bank of China, Limited by Share Ltd, Xifeng county subbranch Pledgor: Taihe Pharmaceutical Co., Ltd., Guizhou Registration number: 2013990000467 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20140717 Granted publication date: 20130213 Pledgee: Agricultural Bank of China, Limited by Share Ltd, Xifeng county subbranch Pledgor: Taihe Pharmaceutical Co., Ltd., Guizhou Registration number: 2013990000467 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tablet used for treating prostate diseases as well as preparation method and application thereof Effective date of registration: 20140718 Granted publication date: 20130213 Pledgee: Agricultural Bank of China, Limited by Share Ltd, Xifeng county subbranch Pledgor: Taihe Pharmaceutical Co., Ltd., Guizhou Registration number: 2014990000585 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20150807 Granted publication date: 20130213 Pledgee: Agricultural Bank of China, Limited by Share Ltd, Xifeng county subbranch Pledgor: Taihe Pharmaceutical Co., Ltd., Guizhou Registration number: 2014990000585 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tablet used for treating prostate diseases as well as preparation method and application thereof Effective date of registration: 20150813 Granted publication date: 20130213 Pledgee: Agricultural Bank of China, Limited by Share Ltd, Xifeng county subbranch Pledgor: Taihe Pharmaceutical Co., Ltd., Guizhou Registration number: 2015990000674 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160926 Granted publication date: 20130213 Pledgee: Agricultural Bank of China, Limited by Share Ltd, Xifeng county subbranch Pledgor: Taihe Pharmaceutical Co., Ltd., Guizhou Registration number: 2015990000674 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tablet used for treating prostate diseases as well as preparation method and application thereof Effective date of registration: 20160927 Granted publication date: 20130213 Pledgee: Agricultural Bank of China, Limited by Share Ltd, Xifeng county subbranch Pledgor: Taihe Pharmaceutical Co., Ltd., Guizhou Registration number: 2016520000013 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20171018 Granted publication date: 20130213 Pledgee: Agricultural Bank of China, Limited by Share Ltd, Xifeng county subbranch Pledgor: Taihe Pharmaceutical Co., Ltd., Guizhou Registration number: 2016520000013 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tablet used for treating prostate diseases as well as preparation method and application thereof Effective date of registration: 20171121 Granted publication date: 20130213 Pledgee: Agricultural Bank of China, Limited by Share Ltd, Xifeng county subbranch Pledgor: Taihe Pharmaceutical Co., Ltd., Guizhou Registration number: 2017520000013 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |